Pharmacoeconomics of the management of acute exacerbations of chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Pharmacoeconomics of the management of acute exacerbations of chronic obstructive pulmonary disease

Published:2007-03-22 Issue:5 Volume:8 Page:633-648
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Simoens Steven,Decramer Marc

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.8.5.633

Reference58 articles.

1. GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Pulmonary Disease workshop summary. MCR VISION, Inc. (2006).

2. Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease

3. Infectious Etiology of Acute Exacerbations of Chronic Bronchitis

4. Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease

5. Evidence-based approach to acute exacerbations of COPD

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. National clinical audit for hospitalised exacerbations of COPD;ERJ Open Research;2020-07

2. COPD: The Annual Cost-Of-Illness during the Last Two Decades in Italy, and Its Mortality Predictivity Power;Healthcare;2019-03-01

3. COPD affects worker productivity and health care costs;International Journal of Chronic Obstructive Pulmonary Disease;2018-07

4. COPD: Economical and Surrogate Outcomes—The Case of COPD;Textbook of Pulmonary Rehabilitation;2017-08-29

5. Indigenous rapid diagnostic technology for antibiotic susceptibility testing in urinary tract infection: from bench side to bedside;BMJ Innovations;2017-01-05